Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia

Journal of the American College of Nutrition

Volumn 17, Issue 5, 1998, Pages 458-461

  Jabbar, Muhammad A ^a   Zuhri Yafi, Mohammed I ^a   Larrea, Jennifer ^a  

^a HURLEY MEDICAL CENTER   (United States)

Author keywords

Fish oil; Gemfibrozil; Hypertriglyceridemia; Insulin

Indexed keywords

FISH OIL; GEMFIBROZIL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CASE REPORT; CHOLESTEROL METABOLISM; DIET SUPPLEMENTATION; DRUG EFFECT; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOLIPEMIA; INSULIN TREATMENT; MALE; TREATMENT PLANNING;

ABDOMINAL PAIN; ADOLESCENT; ANTILIPEMIC AGENTS; CHOLESTEROL; FISH OILS; GEMFIBROZIL; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; LIPOPROTEINS, HDL; MALE; PUBERTY; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0031662381     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1998.10718794     Document Type: Article

References (13)

1. Farmer RG, Winkelman EI, Brown HB, Lewis LA: Hyperlipoproteinemia and pancreatitis. Am J Med 54:161-165, 1973.
2. Hulley SB, Rosenman RH, Bawol RD, Brand RJ: Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 302:1383, 1980.
3. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden M: Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 335:848-854, 1996.
4. Austin MA: plasma TG as a risk factor for CHD: the epidemiologic evidence and beyond. Am J Epidemiolol 129:249-259, 1989.
5. Goodnight SH Jr, Harris WS, Connor WE, Illingworth DR: Polyunsaturated fatty acids, hyperlipidemia and thrombosis. Arteriosclerosis 2:87-113, 1982.
6. Donnelly SM, Ali MA, Churchill DN: Effect of n-3 fatty acids from fish oil on hemostasis, BP, lipid profile of dialysis patient. J Am Soc Nephrology 2:1634-1639, 1992.
7. Helsinky Heart Study: Primary Prevention Trial with gemfibrozil in middle-aged men with dyslipidemia. Study of treatment, changes in trisk factors and incidence of coronary heart disease. Frick MH, Elo O. N Engl J Med 317:1237-1245, 1987.
8. Bierman EI, Glomset JA: Disorders of lipid metabolism. In Wilson JD, Foster DW (eds): “Williams Textbook of Endocrinology, ” 8th ed. Philadelphia: W.B. Saunders Company, pp 1380-1381, 1992.
9. Chait A, Bruzzell JD: Severe hypertriglyceridemia: role of familial and acquired disorders. Metabolism 32:209-214, 1983.
10. Belluzzi A, Corrado B, Campieri M, Pera A, Boschi S, Miglioli M: Effect of enteric-coated fish-oil preparation on relapses in Chrohn’s disease. N Engl J Med 334:1557-1560, 1996.
11. Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A: Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. Arteriosclerosis 8:227-236, 1988.
12. Brunzell JD: Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome: In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): “The Metabolic and Molecular Basis of Inherited Disease, ” 7th ed. New York: McGraw Hill, pp 1916- 1919, 1995.
13. American Academy of Pediatrics. Statement on cholesterol. Committee on Nutrition 90:469-473, 1992.